Atlas Trials

Anti-angiogenesis Combine With EGFR-TKI in Advanced Non-squamous Non Small Cell Lung Cancer

Clinical trial NCT03461185 · UNKNOWN

Trial details

NCT number
NCT03461185
Sponsor
Xinqiao Hospital of Chongqing
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Non Small Cell Lung Cancer
Start date
2018-05-01
Primary completion
2019-08-30
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.